Early nerve ending rescue from oxidative damage and energy failure by l-carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities

Cell rescue is a primary need during acute and chronic insults to the central nervous system. Functional preservation during the early stages of toxicity in a given degenerative event may represent a significant amelioration of detrimental processes linked to neuronal cell loss. Excitotoxicity and d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental brain research 2009-08, Vol.197 (3), p.287-296
Hauptverfasser: Elinos-Calderón, Diana, Robledo-Arratia, Yolanda, Pérez-De La Cruz, Verónica, Pedraza-Chaverrí, José, Ali, Syed F, Santamaría, Abel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 296
container_issue 3
container_start_page 287
container_title Experimental brain research
container_volume 197
creator Elinos-Calderón, Diana
Robledo-Arratia, Yolanda
Pérez-De La Cruz, Verónica
Pedraza-Chaverrí, José
Ali, Syed F
Santamaría, Abel
description Cell rescue is a primary need during acute and chronic insults to the central nervous system. Functional preservation during the early stages of toxicity in a given degenerative event may represent a significant amelioration of detrimental processes linked to neuronal cell loss. Excitotoxicity and depleted cellular energy are toxic events leading to cell death in several neurodegenerative disorders. In this work, the effects of the well-known antioxidant and energy precursor, l-carnitine (l-CAR), were tested as a post-treatment in two neurotoxic models under in vitro and in vivo conditions. The experimental models tested included: (1) a typical excitotoxic and pro-oxidant inducer, quinolinic acid (QUIN); and (2) a mitochondrial energy inhibitor, 3-nitropropionic acid (3-NP). For in vitro studies, increasing concentrations of l-CAR (10-1,000 μM) were added to the isolated brain synaptosomes at different times (1, 3 and 6 h) after the incubation with toxins (100 μM QUIN and 1 mM 3-NP), and 30 min later, lipid peroxidation (LP) and mitochondrial dysfunction (MD) were evaluated. For in vivo purposes, l-CAR (100 mg/kg, i.p.) was given to rats either as a single administration 120 min after the intrastriatal infusion of QUIN (240 nmol/μl) or 3-NP (500 nmol/μl), or for 7 consecutive days (starting 120 min post-lesion). LP and MD were evaluated 4 h and 7 days post-lesions in isolated striatal synaptosomes. Our results show that, despite some variations depending on the toxic model tested, the time of exposure, or the biomarker evaluated, nerve ending protection can be mostly achieved by l-CAR within the first hours after the toxic insults started, suggesting that targeting the ongoing oxidative damage and/or energy depletion during the first stages of neurotoxic events is essential to rescue nerve endings.
doi_str_mv 10.1007/s00221-009-1913-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20232000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1818331401</sourcerecordid><originalsourceid>FETCH-LOGICAL-c454t-ec88279c5326db156a1f37be22e94f4a0fed79b506b9199c6a769190a05eb04f3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhiMEokvhB3ABCwlugbHjOAk3VJUPqRIH6NmaOOOVq8RebKewP4z_h7e7ohIHTnE0zzvPSG9VPefwlgN07xKAELwGGGo-8KZuHlQbLhtRcw7qYbUB4LKWPR_Oqicp3Rx-mw4eV2d8aFUrhNxUvy8xznvmKd4SIz85v2WRklmJ2RgWFn65CbMrwwkX3BJDPxWO4nbPLLp5jcTGPZtrg9G77HwhEtuFlOscCfNCPjPnWf4ZimSNIZeNhi1hojkdBhHz-2I04ZbingVbBNndWUvwIIs0rebuAoM7NMVB6Wn1yOKc6Nnpe15df7z8fvG5vvr66cvFh6vayFbmmkzfi24wbSPUNPJWIbdNN5IQNEgrESxN3TC2oMaBD4NR2KnyAISWRpC2Oa_eHPfuYvixUsp6ccnQPKOnsCYtQDQCAAr46h_wJqzRl9u04C0XfS_7AvEjZGJIKZLVu-gWjHvNQR8K1cdCdSlUHwrVTcm8OC1ex4Wm-8SpwQK8PgGYDM42ojcu_eUE7wGUEoUTRy6Vkd9SvL_wf_aXx5DFoHEby-LrbwJ4A1wpLov-D4T7xH8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215128848</pqid></control><display><type>article</type><title>Early nerve ending rescue from oxidative damage and energy failure by l-carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Elinos-Calderón, Diana ; Robledo-Arratia, Yolanda ; Pérez-De La Cruz, Verónica ; Pedraza-Chaverrí, José ; Ali, Syed F ; Santamaría, Abel</creator><creatorcontrib>Elinos-Calderón, Diana ; Robledo-Arratia, Yolanda ; Pérez-De La Cruz, Verónica ; Pedraza-Chaverrí, José ; Ali, Syed F ; Santamaría, Abel</creatorcontrib><description>Cell rescue is a primary need during acute and chronic insults to the central nervous system. Functional preservation during the early stages of toxicity in a given degenerative event may represent a significant amelioration of detrimental processes linked to neuronal cell loss. Excitotoxicity and depleted cellular energy are toxic events leading to cell death in several neurodegenerative disorders. In this work, the effects of the well-known antioxidant and energy precursor, l-carnitine (l-CAR), were tested as a post-treatment in two neurotoxic models under in vitro and in vivo conditions. The experimental models tested included: (1) a typical excitotoxic and pro-oxidant inducer, quinolinic acid (QUIN); and (2) a mitochondrial energy inhibitor, 3-nitropropionic acid (3-NP). For in vitro studies, increasing concentrations of l-CAR (10-1,000 μM) were added to the isolated brain synaptosomes at different times (1, 3 and 6 h) after the incubation with toxins (100 μM QUIN and 1 mM 3-NP), and 30 min later, lipid peroxidation (LP) and mitochondrial dysfunction (MD) were evaluated. For in vivo purposes, l-CAR (100 mg/kg, i.p.) was given to rats either as a single administration 120 min after the intrastriatal infusion of QUIN (240 nmol/μl) or 3-NP (500 nmol/μl), or for 7 consecutive days (starting 120 min post-lesion). LP and MD were evaluated 4 h and 7 days post-lesions in isolated striatal synaptosomes. Our results show that, despite some variations depending on the toxic model tested, the time of exposure, or the biomarker evaluated, nerve ending protection can be mostly achieved by l-CAR within the first hours after the toxic insults started, suggesting that targeting the ongoing oxidative damage and/or energy depletion during the first stages of neurotoxic events is essential to rescue nerve endings.</description><identifier>ISSN: 0014-4819</identifier><identifier>EISSN: 1432-1106</identifier><identifier>DOI: 10.1007/s00221-009-1913-3</identifier><identifier>PMID: 19565224</identifier><identifier>CODEN: EXBRAP</identifier><language>eng</language><publisher>Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag</publisher><subject>Animals ; Antioxidants ; Antioxidants - pharmacology ; Antioxidants - therapeutic use ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Brain - drug effects ; Brain - metabolism ; Brain - physiopathology ; Brain research ; Carnitine - pharmacology ; Carnitine - therapeutic use ; Cell death ; Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Energy ; Energy Metabolism - drug effects ; Energy Metabolism - physiology ; Enzyme Inhibitors - metabolism ; Enzyme Inhibitors - toxicity ; Fundamental and applied biological sciences. Psychology ; Lipid peroxidation ; Lipids ; Male ; Medical sciences ; Mitochondria - drug effects ; Mitochondria - metabolism ; Motor control and motor pathways. Reflexes. Control centers of vegetative functions. Vestibular system and equilibration ; Nervous system ; Nervous system (semeiology, syndromes) ; Neurology ; Neurosciences ; Neurotoxicity ; Neurotoxins - antagonists &amp; inhibitors ; Neurotoxins - metabolism ; Nitro Compounds - antagonists &amp; inhibitors ; Nitro Compounds - metabolism ; Oxidants - antagonists &amp; inhibitors ; Oxidants - metabolism ; Oxidation-Reduction - drug effects ; Oxidative stress ; Oxidative Stress - drug effects ; Oxidative Stress - physiology ; Presynaptic Terminals - drug effects ; Presynaptic Terminals - metabolism ; Propionates - antagonists &amp; inhibitors ; Propionates - metabolism ; Quinolinic Acid - antagonists &amp; inhibitors ; Quinolinic Acid - metabolism ; Rats ; Rats, Wistar ; Research Article ; Synaptosomes ; Toxicity ; Vertebrates: nervous system and sense organs ; Vitamin B Complex - pharmacology ; Vitamin B Complex - therapeutic use</subject><ispartof>Experimental brain research, 2009-08, Vol.197 (3), p.287-296</ispartof><rights>Springer-Verlag 2009</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c454t-ec88279c5326db156a1f37be22e94f4a0fed79b506b9199c6a769190a05eb04f3</citedby><cites>FETCH-LOGICAL-c454t-ec88279c5326db156a1f37be22e94f4a0fed79b506b9199c6a769190a05eb04f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00221-009-1913-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00221-009-1913-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21800662$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19565224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elinos-Calderón, Diana</creatorcontrib><creatorcontrib>Robledo-Arratia, Yolanda</creatorcontrib><creatorcontrib>Pérez-De La Cruz, Verónica</creatorcontrib><creatorcontrib>Pedraza-Chaverrí, José</creatorcontrib><creatorcontrib>Ali, Syed F</creatorcontrib><creatorcontrib>Santamaría, Abel</creatorcontrib><title>Early nerve ending rescue from oxidative damage and energy failure by l-carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities</title><title>Experimental brain research</title><addtitle>Exp Brain Res</addtitle><addtitle>Exp Brain Res</addtitle><description>Cell rescue is a primary need during acute and chronic insults to the central nervous system. Functional preservation during the early stages of toxicity in a given degenerative event may represent a significant amelioration of detrimental processes linked to neuronal cell loss. Excitotoxicity and depleted cellular energy are toxic events leading to cell death in several neurodegenerative disorders. In this work, the effects of the well-known antioxidant and energy precursor, l-carnitine (l-CAR), were tested as a post-treatment in two neurotoxic models under in vitro and in vivo conditions. The experimental models tested included: (1) a typical excitotoxic and pro-oxidant inducer, quinolinic acid (QUIN); and (2) a mitochondrial energy inhibitor, 3-nitropropionic acid (3-NP). For in vitro studies, increasing concentrations of l-CAR (10-1,000 μM) were added to the isolated brain synaptosomes at different times (1, 3 and 6 h) after the incubation with toxins (100 μM QUIN and 1 mM 3-NP), and 30 min later, lipid peroxidation (LP) and mitochondrial dysfunction (MD) were evaluated. For in vivo purposes, l-CAR (100 mg/kg, i.p.) was given to rats either as a single administration 120 min after the intrastriatal infusion of QUIN (240 nmol/μl) or 3-NP (500 nmol/μl), or for 7 consecutive days (starting 120 min post-lesion). LP and MD were evaluated 4 h and 7 days post-lesions in isolated striatal synaptosomes. Our results show that, despite some variations depending on the toxic model tested, the time of exposure, or the biomarker evaluated, nerve ending protection can be mostly achieved by l-CAR within the first hours after the toxic insults started, suggesting that targeting the ongoing oxidative damage and/or energy depletion during the first stages of neurotoxic events is essential to rescue nerve endings.</description><subject>Animals</subject><subject>Antioxidants</subject><subject>Antioxidants - pharmacology</subject><subject>Antioxidants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Brain - physiopathology</subject><subject>Brain research</subject><subject>Carnitine - pharmacology</subject><subject>Carnitine - therapeutic use</subject><subject>Cell death</subject><subject>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</subject><subject>Disease Models, Animal</subject><subject>Dose-Response Relationship, Drug</subject><subject>Energy</subject><subject>Energy Metabolism - drug effects</subject><subject>Energy Metabolism - physiology</subject><subject>Enzyme Inhibitors - metabolism</subject><subject>Enzyme Inhibitors - toxicity</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Lipid peroxidation</subject><subject>Lipids</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Motor control and motor pathways. Reflexes. Control centers of vegetative functions. Vestibular system and equilibration</subject><subject>Nervous system</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neurosciences</subject><subject>Neurotoxicity</subject><subject>Neurotoxins - antagonists &amp; inhibitors</subject><subject>Neurotoxins - metabolism</subject><subject>Nitro Compounds - antagonists &amp; inhibitors</subject><subject>Nitro Compounds - metabolism</subject><subject>Oxidants - antagonists &amp; inhibitors</subject><subject>Oxidants - metabolism</subject><subject>Oxidation-Reduction - drug effects</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - physiology</subject><subject>Presynaptic Terminals - drug effects</subject><subject>Presynaptic Terminals - metabolism</subject><subject>Propionates - antagonists &amp; inhibitors</subject><subject>Propionates - metabolism</subject><subject>Quinolinic Acid - antagonists &amp; inhibitors</subject><subject>Quinolinic Acid - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Research Article</subject><subject>Synaptosomes</subject><subject>Toxicity</subject><subject>Vertebrates: nervous system and sense organs</subject><subject>Vitamin B Complex - pharmacology</subject><subject>Vitamin B Complex - therapeutic use</subject><issn>0014-4819</issn><issn>1432-1106</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU1v1DAQhiMEokvhB3ABCwlugbHjOAk3VJUPqRIH6NmaOOOVq8RebKewP4z_h7e7ohIHTnE0zzvPSG9VPefwlgN07xKAELwGGGo-8KZuHlQbLhtRcw7qYbUB4LKWPR_Oqicp3Rx-mw4eV2d8aFUrhNxUvy8xznvmKd4SIz85v2WRklmJ2RgWFn65CbMrwwkX3BJDPxWO4nbPLLp5jcTGPZtrg9G77HwhEtuFlOscCfNCPjPnWf4ZimSNIZeNhi1hojkdBhHz-2I04ZbingVbBNndWUvwIIs0rebuAoM7NMVB6Wn1yOKc6Nnpe15df7z8fvG5vvr66cvFh6vayFbmmkzfi24wbSPUNPJWIbdNN5IQNEgrESxN3TC2oMaBD4NR2KnyAISWRpC2Oa_eHPfuYvixUsp6ccnQPKOnsCYtQDQCAAr46h_wJqzRl9u04C0XfS_7AvEjZGJIKZLVu-gWjHvNQR8K1cdCdSlUHwrVTcm8OC1ex4Wm-8SpwQK8PgGYDM42ojcu_eUE7wGUEoUTRy6Vkd9SvL_wf_aXx5DFoHEby-LrbwJ4A1wpLov-D4T7xH8</recordid><startdate>20090801</startdate><enddate>20090801</enddate><creator>Elinos-Calderón, Diana</creator><creator>Robledo-Arratia, Yolanda</creator><creator>Pérez-De La Cruz, Verónica</creator><creator>Pedraza-Chaverrí, José</creator><creator>Ali, Syed F</creator><creator>Santamaría, Abel</creator><general>Berlin/Heidelberg : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88J</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2R</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20090801</creationdate><title>Early nerve ending rescue from oxidative damage and energy failure by l-carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities</title><author>Elinos-Calderón, Diana ; Robledo-Arratia, Yolanda ; Pérez-De La Cruz, Verónica ; Pedraza-Chaverrí, José ; Ali, Syed F ; Santamaría, Abel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c454t-ec88279c5326db156a1f37be22e94f4a0fed79b506b9199c6a769190a05eb04f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antioxidants</topic><topic>Antioxidants - pharmacology</topic><topic>Antioxidants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Brain - physiopathology</topic><topic>Brain research</topic><topic>Carnitine - pharmacology</topic><topic>Carnitine - therapeutic use</topic><topic>Cell death</topic><topic>Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction</topic><topic>Disease Models, Animal</topic><topic>Dose-Response Relationship, Drug</topic><topic>Energy</topic><topic>Energy Metabolism - drug effects</topic><topic>Energy Metabolism - physiology</topic><topic>Enzyme Inhibitors - metabolism</topic><topic>Enzyme Inhibitors - toxicity</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Lipid peroxidation</topic><topic>Lipids</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Motor control and motor pathways. Reflexes. Control centers of vegetative functions. Vestibular system and equilibration</topic><topic>Nervous system</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neurosciences</topic><topic>Neurotoxicity</topic><topic>Neurotoxins - antagonists &amp; inhibitors</topic><topic>Neurotoxins - metabolism</topic><topic>Nitro Compounds - antagonists &amp; inhibitors</topic><topic>Nitro Compounds - metabolism</topic><topic>Oxidants - antagonists &amp; inhibitors</topic><topic>Oxidants - metabolism</topic><topic>Oxidation-Reduction - drug effects</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - physiology</topic><topic>Presynaptic Terminals - drug effects</topic><topic>Presynaptic Terminals - metabolism</topic><topic>Propionates - antagonists &amp; inhibitors</topic><topic>Propionates - metabolism</topic><topic>Quinolinic Acid - antagonists &amp; inhibitors</topic><topic>Quinolinic Acid - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Research Article</topic><topic>Synaptosomes</topic><topic>Toxicity</topic><topic>Vertebrates: nervous system and sense organs</topic><topic>Vitamin B Complex - pharmacology</topic><topic>Vitamin B Complex - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elinos-Calderón, Diana</creatorcontrib><creatorcontrib>Robledo-Arratia, Yolanda</creatorcontrib><creatorcontrib>Pérez-De La Cruz, Verónica</creatorcontrib><creatorcontrib>Pedraza-Chaverrí, José</creatorcontrib><creatorcontrib>Ali, Syed F</creatorcontrib><creatorcontrib>Santamaría, Abel</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Social Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Experimental brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elinos-Calderón, Diana</au><au>Robledo-Arratia, Yolanda</au><au>Pérez-De La Cruz, Verónica</au><au>Pedraza-Chaverrí, José</au><au>Ali, Syed F</au><au>Santamaría, Abel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Early nerve ending rescue from oxidative damage and energy failure by l-carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities</atitle><jtitle>Experimental brain research</jtitle><stitle>Exp Brain Res</stitle><addtitle>Exp Brain Res</addtitle><date>2009-08-01</date><risdate>2009</risdate><volume>197</volume><issue>3</issue><spage>287</spage><epage>296</epage><pages>287-296</pages><issn>0014-4819</issn><eissn>1432-1106</eissn><coden>EXBRAP</coden><abstract>Cell rescue is a primary need during acute and chronic insults to the central nervous system. Functional preservation during the early stages of toxicity in a given degenerative event may represent a significant amelioration of detrimental processes linked to neuronal cell loss. Excitotoxicity and depleted cellular energy are toxic events leading to cell death in several neurodegenerative disorders. In this work, the effects of the well-known antioxidant and energy precursor, l-carnitine (l-CAR), were tested as a post-treatment in two neurotoxic models under in vitro and in vivo conditions. The experimental models tested included: (1) a typical excitotoxic and pro-oxidant inducer, quinolinic acid (QUIN); and (2) a mitochondrial energy inhibitor, 3-nitropropionic acid (3-NP). For in vitro studies, increasing concentrations of l-CAR (10-1,000 μM) were added to the isolated brain synaptosomes at different times (1, 3 and 6 h) after the incubation with toxins (100 μM QUIN and 1 mM 3-NP), and 30 min later, lipid peroxidation (LP) and mitochondrial dysfunction (MD) were evaluated. For in vivo purposes, l-CAR (100 mg/kg, i.p.) was given to rats either as a single administration 120 min after the intrastriatal infusion of QUIN (240 nmol/μl) or 3-NP (500 nmol/μl), or for 7 consecutive days (starting 120 min post-lesion). LP and MD were evaluated 4 h and 7 days post-lesions in isolated striatal synaptosomes. Our results show that, despite some variations depending on the toxic model tested, the time of exposure, or the biomarker evaluated, nerve ending protection can be mostly achieved by l-CAR within the first hours after the toxic insults started, suggesting that targeting the ongoing oxidative damage and/or energy depletion during the first stages of neurotoxic events is essential to rescue nerve endings.</abstract><cop>Berlin/Heidelberg</cop><pub>Berlin/Heidelberg : Springer-Verlag</pub><pmid>19565224</pmid><doi>10.1007/s00221-009-1913-3</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4819
ispartof Experimental brain research, 2009-08, Vol.197 (3), p.287-296
issn 0014-4819
1432-1106
language eng
recordid cdi_proquest_miscellaneous_20232000
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Animals
Antioxidants
Antioxidants - pharmacology
Antioxidants - therapeutic use
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Brain - drug effects
Brain - metabolism
Brain - physiopathology
Brain research
Carnitine - pharmacology
Carnitine - therapeutic use
Cell death
Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction
Disease Models, Animal
Dose-Response Relationship, Drug
Energy
Energy Metabolism - drug effects
Energy Metabolism - physiology
Enzyme Inhibitors - metabolism
Enzyme Inhibitors - toxicity
Fundamental and applied biological sciences. Psychology
Lipid peroxidation
Lipids
Male
Medical sciences
Mitochondria - drug effects
Mitochondria - metabolism
Motor control and motor pathways. Reflexes. Control centers of vegetative functions. Vestibular system and equilibration
Nervous system
Nervous system (semeiology, syndromes)
Neurology
Neurosciences
Neurotoxicity
Neurotoxins - antagonists & inhibitors
Neurotoxins - metabolism
Nitro Compounds - antagonists & inhibitors
Nitro Compounds - metabolism
Oxidants - antagonists & inhibitors
Oxidants - metabolism
Oxidation-Reduction - drug effects
Oxidative stress
Oxidative Stress - drug effects
Oxidative Stress - physiology
Presynaptic Terminals - drug effects
Presynaptic Terminals - metabolism
Propionates - antagonists & inhibitors
Propionates - metabolism
Quinolinic Acid - antagonists & inhibitors
Quinolinic Acid - metabolism
Rats
Rats, Wistar
Research Article
Synaptosomes
Toxicity
Vertebrates: nervous system and sense organs
Vitamin B Complex - pharmacology
Vitamin B Complex - therapeutic use
title Early nerve ending rescue from oxidative damage and energy failure by l-carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T22%3A01%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Early%20nerve%20ending%20rescue%20from%20oxidative%20damage%20and%20energy%20failure%20by%20l-carnitine%20as%20post-treatment%20in%20two%20neurotoxic%20models%20in%20rat:%20recovery%20of%20antioxidant%20and%20reductive%20capacities&rft.jtitle=Experimental%20brain%20research&rft.au=Elinos-Calder%C3%B3n,%20Diana&rft.date=2009-08-01&rft.volume=197&rft.issue=3&rft.spage=287&rft.epage=296&rft.pages=287-296&rft.issn=0014-4819&rft.eissn=1432-1106&rft.coden=EXBRAP&rft_id=info:doi/10.1007/s00221-009-1913-3&rft_dat=%3Cproquest_cross%3E1818331401%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215128848&rft_id=info:pmid/19565224&rfr_iscdi=true